Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.
Daiichi Sankyo announced the receipt of marketing approval in Japan for Tarlige tablets 2.5 mg, 5 mg, 10 mg, 15 mg for the treatment of peripheral neuropathic pain (PNP).
Vinoba Bhave Research Institute (VBRI) sees that network of medical sensory devices will facilitate virtual and remote clinics for accurate treatment. It will also build a SaaS/PaaS model to fully utilize the
CPhI & P─MEC China 2019, the most comprehensive pharmaceutical exhibition in Asia covering the entire industry chain, will be held at SNIEC, Shanghai from June 18─20, 2019. The annual pharma gala are expected to
MobileHelp, a leader in mobile Personal Emergency Response Systems (mPERS) and healthcare solutions, and LifePod Solutions, will be unveiling a proactive voice service enhanced with emergency response,
Vifor Pharma, a global pharmaceutical company focused in iron deficiency, nephrology and cardio─renal therapies, reported positive phase─I trial results for its oral ferroportin inhibitor. The trial which was
Vital Therapies, Inc., and Immunic AG (Immunic), a private clinical─stage biotechnology company in Planegg─Martinsried, Germany, announced that they have entered into a definitive agreement under which Vital
Indian Pharmaceutical companies and their subsidiaries have established strong presence in US during last couple of years with higher ANDA approvals. The loss of patent exclusivity and cost cutting measures
More than four decades after releasing the national list of essential medicines, India has now drafted the first national essential diagnostics list which is a country─specific set of tests for detecting common morbid conditions and priority diseases in the country.
Indian healthcare requires a combination of local and imported medical devices for improved patient outcomes. The sector is in an exciting phase of development. The increasing regulations will enable Indians receive
CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for CTX001 for the treatment of sickle cell
Medical Technology Association of India (MTaI), which represents leading research─based medical technology companies, said the formation of the Drugs Technical Advisory Board (DTAB)
The hospital sector witnessed challenging times in 2018 with various regulatory restrictions from multiple authorities, affecting the average revenue per occupied bed day (ARPOB) of the players.
Urging immediate attention of the state and central governments to address the various problems faced by the Pharm D professionals in the country, the Doctor of Pharmacy Association has recently written to Prime Minister Narendra Modi
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced that the company achieved an undisclosed milestone payment from Merus N.V based on Merus'
The International Hologram Manufacturers Association (IHMA), which represents the global hologram industry, has appointed a new chairman and board.
BioPhotas, Inc., the market leader in therapeutic LED Light Therapy devices, announced a major product line extension to the company's Celluma Series of Light Therapy Devices.
Merck known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) announced that Merck has exercised its option to license NGM313, an investigational monoclonal antibody
Biogen Inc. announced that the first patient has been enrolled in a global phase 3b study evaluating the efficacy and safety of extended interval dosing (EID; every six weeks) for natalizumab compared to standard
In its ongoing crackdown on unscrupulous drug dealers for trading immunoglobulin injections in the open market, the Maharshtra Food and Drug Administration (FDA) has filed FIRs against 3 more persons for violation of sections 420
Merck, known as MSD outside the United States and Canada, announced that Keytruda, Merck's anti─PD─1 therapy, has simultaneously received five new approvals from the Japan Pharmaceuticals and Medical Devices
NPPA notification dated December 21, 2o018 fixing/revising ceiling prices/retail prices of 24 formulations under Drugs (Prices Control) Order, 2013
BrainScope, a medical neuro─technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, has received FDA clearance to include additional language in its product's Indications
Norgine B V (Norgine), a leading European specialist pharmaceutical company and Korea Pharma Co Ltd. (Korea Pharma), a premier pharmaceutical manufacturer in Korea, announced an exclusive licence
In yet another major crackdown on spurious drugs, the Gujarat Food and Drug Control Administration (FDCA) has detected a herbal drug manufacturer──Babaji Herbal Company based in Punjab for supplying
HydRx Farms Ltd (o/a Scientus Pharma), a biopharmaceutical company conducting research and product development for extracts and formulations related to medical cannabinoids and their derivatives, has